NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/30/2026
Back to search
Official data from USPTO
R
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
07/30/2026
Trademark type
Combined
Nice classes
5
Filing date
10/17/2016
Registration date
07/04/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/19/2024
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CH
Examiner
MURRAY, DAVID T
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized letter "R" with a beaker design forming the left side of the letter "R".
Holders and representatives
Holders
RIVOPHARM S.A.
Representatives
Jeffrey B. Sladkus The Sladkus Law Group
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsboth prescription and over-the-counterpharmaceutical preparations for peptic ulcer and gastrooesophageal reflux disease (GORD)propulsivesintestinal anti-infectivesintestinal anti-inflammatory agentsoral pharmaceutical preparations for lowering blood glucoseVitamin A and Dmixed vitamin preparations consisting of vitamins A and Dvitamin and mineral preparations for medical usevitamin C in the nature of ascorbic acid mixed vitamin preparations consisting partially of Vitamin Ccalcium supplementsmineral supplementsanti-thrombotic agentsintravenous solutionscardiac glycosidesclass I and class III anti-arrhythmicspharmaceutical preparations for cardiac stimulation excluding cardiac glycosidesVasodilators used in the treatment of cardiac diseasesanti-adrenergic agentspharmaceutical preparations for acting on arteriolar smooth muscleBeta blocking agentsSelective calcium channel blockerspharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitorspharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors combined with other pharmaceutical preparationsanti-fungals for systemic useanti-infectives and antisepticsexcluding those combined with corticosteroidsoxytocicsplain corticosteroids for systemic usethyroid preparationsanti-thyroid preparationstetracyclines preparationsmacrolideslincosamides and streptograminsaminoglycoside antibacterialsquinolone antibacterialsantimycotics for systemic usedirect acting antiviralsimmune serabacterial vaccinesalkylating agentsanti-metabolitesplant alkaloidscytotoxic antibioticshormone antagonists and related agentsanti-estrogensanti-androgens and enzyme inhibitorsimmunosuppressive agentsantiinflammatory and antirheumatic preparationsnon-steroids in the nature of butylpyrazolidinesacetic acid derivativesoxicamspropionic acid derivativesfenamatesCoxibsmuscle relaxantsperipherally acting agents in the nature of curare alkaloids and choline derivativesantigout preparationsanalgesics and antipyretics preparationsanti-migraine preparationsanti-epileptic preparationsanti-cholinergic agentsdopaminergic agentsanti-psychoticsanxiolyticshypnotics and sedativesantidepressantsparasympathomimeticsagents for use against amoebiasis and other protozoal diseasesanti-malarial preparationadrenergicsinhalant anestheticsadrenergics for systemic useantihistamines for systemic usediuretic agents
Publications
History of USPTO decisions and trademark events.
36 publications found
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
11/17/2024
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/24/2024
INPC
INVALIDATION PROCESSED
09/24/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/20/2024
C71T
CANCELLED SECTION 71
01/19/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/04/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/03/2017
GPNX
NOTIFICATION PROCESSED BY IB
10/13/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/05/2017
FIMP
FINAL DISPOSITION PROCESSED
10/05/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/04/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/18/2017
PUBO
PUBLISHED FOR OPPOSITION
04/18/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/29/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/29/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/29/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2017
DMCC
DATA MODIFICATION COMPLETED
03/06/2017
ALIE
ASSIGNED TO LIE
03/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/02/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/01/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/01/2017
RFNT
REFUSAL PROCESSED BY IB
12/09/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/15/2016
RFRR
REFUSAL PROCESSED BY MPU
11/15/2016
MAFR
APPLICATION FILING RECEIPT MAILED
11/11/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/09/2016
CNRT
NON-FINAL ACTION WRITTEN
11/08/2016
DOCK
ASSIGNED TO EXAMINER
11/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2016
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
11/03/2016
Continuous trademark protection
Get notified about every new filing that threatens R or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.